Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCLDisease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Sezary syndrome, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mycosis fungoides, neoplasm, primary cutaneous T-cell non-Hodgkin lymphomaRecruitingPhase 22026-09-09NCT06854653

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Prescient Therapeutics, Ltd.1

15 results · Page 1 of 1

Swipe the table sideways for more columns.